Challenges and Opportunities for Deliberative Processes for Healthcare Decision-Making Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Articles in Press, Corrected Proof, Available Online from 01 August 2022

10.34172/ijhpm.2022.7458

Kenneth Bond

• View Article
• PDF 386.18 K

Three Approaches to Improve a Practical Guide on Evidence-Informed Deliberative Processes for Health Benefit Package Design; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Articles in Press, Corrected Proof, Available Online from 14 August 2022

10.34172/ijhpm.2022.7502

Javier Guzman

• View Article
• PDF 348.71 K

Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design; Comment on “Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide”

Articles in Press, Accepted Manuscript, Available Online from 30 November 2022

Michael J. DiStefano

• View Article
• Author Accepted Version

Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework

Volume 11, Issue 10, October 2022, Pages 2319-2326

10.34172/ijhpm.2021.158

Rob Baltussen; Maarten Jansen; Wija oortwijn

• View Article
• PDF 717.4 K

Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide

Volume 11, Issue 10, October 2022, Pages 2327-2336

10.34172/ijhpm.2021.159

Wija Oortwijn; Maarten Jansen; Rob Baltussen

• View Article
• PDF 699.38 K

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

Volume 11, Issue 5, May 2022, Pages 642-650

10.34172/ijhpm.2020.198

Rick A. Vreman; Lourens T. Bloem; Stijn van Oirschot; Jarno Hoekman; Menno E. van der Elst; Hubert GM Leufkens; Olaf H. Klungel; Wim G. Goettsch; Aukje K. Mantel-Teeuwisse

• View Article
• PDF 754.38 K

Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy

Volume 11, Issue 3, March 2022, Pages 374-382

10.34172/ijhpm.2020.144

Avram E. Denburg; Mita Giacomini; Wendy Ungar; Julia Abelson

• View Article
• PDF 533.41 K

Experiences of Using Cochrane Systematic Reviews by Local HTA Units

Volume 11, Issue 2, February 2022, Pages 112-117

10.34172/ijhpm.2020.133

Thomas G. Poder; Marc Rhainds; Christian A. Bellemare; Simon Deblois; Imane Hammana; Catherine Safianyk; Sylvie St-Jacques; Pierre Dagenais

• View Article
• PDF 681.91 K

A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

Volume 11, Issue 2, February 2022, Pages 128-137

10.34172/ijhpm.2020.86

Magdalena Bujar; Neil McAuslane; Stuart Walker; Sam Salek

• View Article
• PDF 1.34 M

Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 10, Issue 4, April 2021, Pages 228-231

10.34172/ijhpm.2020.46

Mireille Goetghebeur; Marjo Cellier

• View Article
• PDF 424.15 K

Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 10, Issue 4, April 2021, Pages 232-236

10.34172/ijhpm.2020.145

Unni Gopinathan; Trygve Ottersen; Pascale-Renée Cyr; Kalipso Chalkidou

• View Article
• PDF 468.32 K

The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 10, Issue 2, February 2021, Pages 98-101

10.15171/ijhpm.2020.17

Hansoo Kim; Stephen Goodall; Danny Liew

• View Article
• PDF 410.53 K

Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 10, Issue 2, February 2021, Pages 102-105

10.15171/ijhpm.2020.18

Carlo Federici; Aleksandra Torbica

• View Article
• PDF 401.57 K

Exploratory, Participatory and Iterative Assessment of Value: A Response to Recent Commentaries

Volume 10, Issue 1, January 2021, Pages 42-44

10.34172/ijhpm.2020.76

Janneke P.C. Grutters; Tim M. Govers; Jorte Nijboer; Marcia Tummers; Gert Jan van der Wilt; Maroeska M. Rovers

• View Article
• PDF 401.34 K

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand

Volume 9, Issue 10, October 2020, Pages 439-447

10.15171/ijhpm.2020.01

Waranya Rattanavipapong; Ritika Kapoor; Yot Teerawattananon; Jos Luttjeboer; Siobhan Botwright; Rachel A. Archer; Birgitte Giersing; Raymond C. W. Hutubessy

• View Article
• PDF 1006.39 K

Early Health Economic Modelling – Optimizing Development for Medical Device Developers?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 9, Issue 9, September 2020, Pages 403-405

10.15171/ijhpm.2019.136

Conor Teljeur; Máirín Ryan

• View Article
• PDF 333.97 K

Characterizing the Validity and Real-World Utility of Health Technology Assessments in Healthcare: Future Directions; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modelling”

Volume 9, Issue 8, August 2020, Pages 352-355

10.15171/ijhpm.2019.132

Nadine K. Zawadzki; Joel W. Hay

• View Article
• PDF 399.62 K

Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed?; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 9, Issue 6, June 2020, Pages 260-262

10.15171/ijhpm.2019.118

Michael F. Drummond

• View Article
• PDF 323.94 K

Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around The Globe

Volume 9, Issue 1, January 2020, Pages 27-33

10.15171/ijhpm.2019.72

Wija Oortwijn; Maarten Jansen; Rob Baltussen

• View Article
• PDF 551.87 K

Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling

Volume 8, Issue 10, October 2019, Pages 575-582

10.15171/ijhpm.2019.36

Janneke P.C. Grutters; Tim Govers; Jorte Nijboer; Marcia Tummers; Gert Jan van der Wilt; Maroeska M. Rovers

• View Article
• PDF 585.85 K

Nurturing Societal Values in and Through Health Innovations; Comment on “What Health System Challenges Should Responsible Innovation in Health Address?”

Volume 8, Issue 10, October 2019, Pages 613-615

10.15171/ijhpm.2019.57

Payam Abrishami; Sjoerd Repping

• View Article
• PDF 380.27 K

Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice; Comment on “Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy”

Volume 8, Issue 2, February 2019, Pages 132-135

10.15171/ijhpm.2018.115

Wanrudee Isaranuwatchai; Ryan Li; Amanda Glassman; Yot Teerawattananon; Anthony J. Culyer; Kalipso Chalkidou

• View Article
• PDF 463 K

Evaluation of Transition to Electronic Prescriptions in Turkey: Perspective of Family Physicians

Volume 8, Issue 1, January 2019, Pages 40-48

10.15171/ijhpm.2018.89

Sinan Bulut; Ahmet Yıldız; Sıdıka Kaya

• View Article
• PDF 1.01 M

The Bright Elusive Butterfly of Value in Health Technology Development; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies”

Volume 7, Issue 1, January 2018, Pages 81-85

10.15171/ijhpm.2017.65

Trisha Greenhalgh; Nick Fahy; Sara Shaw

• View Article
• PDF 973.1 K

Collaboration Between Researchers and Knowledge Users in Health Technology Assessment: A Qualitative Exploratory Study

Volume 6, Issue 8, August 2017, Pages 437-446

10.15171/ijhpm.2016.153

Mylène Tantchou Dipankui

• View Article
• PDF 664.82 K